Navigation Links
H1N1 'Swine' Flu Makes a Comeback in Mexico
Date:2/10/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 10 (HealthDay News) -- It was just about three years ago that a strange new strain of flu first appeared in Mexico, then spread across the border to the United States and eventually much of the globe.

The H1N1 "swine" flu strain didn't behave like a "normal" flu, because it proved particularly dangerous to children and younger adults -- the very groups of people who usually have the strongest defenses against seasonal flu.

After a quiet couple of years, more cases of the pandemic H1N1 flu are circulating again where it all began -- in Mexico.

But infectious disease experts says Americans shouldn't be overly concerned.

In January, there were 1,623 cases of flu reported in Mexico, and 90 percent of those cases were H1N1 flu. There were also 32 flu-related deaths, all but three caused by the H1N1 strain, the Associated Press reported.

"It appears that H1N1 in Mexico is circulating at a higher level than in the United States," said Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention. "We have seen some H1N1 here in the U.S.," he added, but the more familiar H3N2 strain is predominating here this winter.

The flu season in the United States has also gotten off to a slow start, Skinner said, but it's expected to pick up in the coming weeks. "Our season usually peaks sometime in February and it's not too late to get a flu shot," he said.

The flu shot for this year -- and last year -- includes protection against the H1N1 strain, Skinner noted.

Infectious disease expert Dr. Marc Siegel, an associate professor of medicine at New York University, doesn't think there's much for Americans to worry about, given the situation in Mexico.

"First of all it [the H1N1 virus] turned out to be a very mild virus," he said.

"One of the reasons Mexico saw a severe outbreak compared with us in 2009 is that i
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Young adults responded well to swine flu
2. How Did Generation X Respond to the H1N1 Swine Flu Epidemic?
3. People hospitalized with asthma less likely to die from swine flu
4. Two U.S. Children Contract New Strain of Swine Flu
5. Swine Flu Shot May Be Cleared of Guillain-Barre Charges
6. Swine flu spread was much wider than first thought, scientists say
7. Tracking Swine Flu Virus in Pigs Reveals Mutations
8. A Year After Its Emergence, H1N1 Swine Flu Lingers
9. Officials See Uptick in H1N1 Swine Flu Cases
10. Swine Flu vaccination: voluntary system works
11. Hormel Institute study makes key finding in stem cell self-renewal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
(Date:5/22/2012)... 2012) Pushed to the brink of survival, the ... ancient system that has helped organisms cope with internal ... an integral part of this system, heat shock protein ... accommodate the genetic changes and profound disturbances in normal ... theorized that inhibiting HSP90 just might render breast cancer ...
(Date:5/22/2012)... PORTLAND, Ore. Women who are unable to ... lung function of their newborns by taking Vitamin ... Oregon Health & Science University Doernbecher Children,s Hospital. ... affect the lung development of the developing baby, ... risk of asthma," said Cindy McEvoy, M.D., M.C.R., ...
(Date:5/22/2012)... May 22 (HealthDay News) -- The number of liver ... a new study finds. Researchers said one reason ... death has become more commonplace, and many of those ... organs aren,t healthy enough to attempt a transplant. Another ... to a condition known as fatty liver disease, which ...
(Date:5/22/2012)... microfluidic chip to test for latent tuberculosis. They hope ... than current testing for the disease. , "Our assay ... said Ying Liu, a research specialist working with Professor ... Engineering. , The team has already conducted testing of ... States. , About one-third of the world,s population is ...
Breaking Medicine News(10 mins):Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... Researchers in Germany have developed a new risk assessment ... and patient's risk of cardiac death. , ECG is ... death can be determined and analysed by the computer.The ... to be calculated.// When the programme has completed its ...
... Researchers in France say that the distorting spectacles can ... balance. They think that the spectacles reset the patient's ... to a long-lasitng cure for some postural problems. ... hemisphere may suffer paralysis down their left side and ...
... of starch, previously thought to be just 'empty calories', actually ... Research Organisation (CSIRO), researchers have revealed that resistant starch could ... cancer. , , ... and China have low rates of bowel cancer even though ...
... has now been developed, which makes the process of providing ... , , The device, called Percutaneous ... involves giving artificial respiration to critically ill patients.// , ... the wall of the trachea,the passage leading to the lungs, ...
... is linked with deliquent behaviour of the chilren later ... Delaney-Black, of Children's Hospital of Michigan, the co author ... in comparison to the teetotallers ,women who drank the ... three times more likely to have a child diagnosed ...
... by the National Institutes of Health, showed that at-risk ... reduced their risk of diabetes by 58%, even without ... type 2 diabetes can sharply reduce the odds through ... data from the nation's first major clinical trial to ...
Other Medicine News:
(Date:5/22/2012)... -- Comprehensive Care Corporation ("CompCare") (OTC BB: CHCR), a ... management services provider for managed care companies throughout ... the first quarter of 2012 ending March 31, ... the quarter. "We are pleased ... modest, for its first quarter of 2012.  This ...
(Date:5/22/2012)... May 22, 2012  Based on its recent ... Sullivan recognizes Labcyte Inc. with the 2012 North ... liquid handler. While various liquid handling technologies provide ... range of advantages provided by the Echo liquid ... handling, Labcyte developed a platform enabling assay miniaturization ...
(Date:5/22/2012)... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical ... Immunodeficiency Virus (HIV) infections, today announced that the ... enrollment for a Phase 1 trial for the ... identical to the first generation (currently ... the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) as ...
Breaking Medicine Technology:Comprehensive Care Corporation Announces Profit for First Quarter 2Comprehensive Care Corporation Announces Profit for First Quarter 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 4Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 5HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4 Some Folks Just Cant Help Being Nice Study Suggests 90172 1 Some Folks Just Cant Help Being Nice Study Suggests 90172 2Power without the cord 90168 1Power without the cord 90168 2Power without the cord 90168 3AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards 90164 1AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards 90164 2
... Ill., March 29, 2007 /PRNewswire-FirstCall/ -- Baxter,International Inc. ... investigational pandemic H5N1 influenza vaccine and,plans to initiate ... in Europe to confirm the study results. , ... candidate,vaccine is highly immunogenic at low doses, and ...
... Valortim-Treated,Animals , PRINCETON, N.J. and ANNAPOLIS, MD., ... a leading monoclonal antibody company, and,PharmAthene, Inc., ... development of biodefense countermeasures, today announced,that Valortim, ... developed for the prevention and treatment of ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
Binkhorst, length 18 mm....
Army/Navy retractor (set of 2)....
Sharp. 4 mm wide. Hand-Held...
Medicine Products: